ArticleVaccine: X2023

A phase-I, open label clinical trial to assess the safety & tolerability of qHPV vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults.

Hitt Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.